Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James C. Garbutt is active.

Publication


Featured researches published by James C. Garbutt.


Psychiatry Research-neuroimaging | 1984

Urinary excretion of bioterin and neopterin in psychiatric disorders

David S. Duch; Jeffrey H. Woolf; Charles A. Nichol; Jonathan R. T. Davidson; James C. Garbutt

Levels of urinary neopterin and biopterin were determined in patients having a diagnosis of schizophrenia, unipolar depression, or bipolar depression. Both neopterin and biopterin levels were significantly higher in the urine of patients with unipolar depression than in the urine of the control group. Subclassification of patients into primary and secondary depression demonstrated a significant elevation of urinary biopterin in both groups, whereas urinary neopterin was elevated only in those patients with primary depression. In patients with bipolar depression, neopterin excretion was elevated, but biopterin excretion did not differ from controls. No significant differences were found in schizophrenic patients.


Psychiatry Research-neuroimaging | 1983

The TRH test in patients with borderline personality disorder

James C. Garbutt; Peter T. Loosen; Alan Tipermas; Arthur J. Prange

Fifteen patients with a primary diagnosis of borderline personality disorder were studied with the thyrotropin-releasing hormone (TRH) test. Twelve carried the additional diagnosis of depression, substance abuse, or both. A blunted thyroid-stimulating hormone (TSH) response to TRH was found in seven patients, two of whom were neither depressed nor had the additional diagnosis of depression and/or substance abuse. TSH blunting was unrelated to such factors as thyroid status, serum cortisol, weight, height, or body surface. Since TSH blunting occurs in about 25% of patients with major depression but not in schizophrenia, the findings suggest that some patients with borderline personality disorder share a neuroendocrine abnormality with some affective disorder patients.


Psychiatry Research-neuroimaging | 1982

Cerebrospinal fluid hydroxylase cofactor in schizophrenia

James C. Garbutt; Daniel P. van Kammen; Robert A. Levine; David E. Sternberg; Dennis L. Murphy; James C. Ballenger; William E. Bunney; Walter Lovenberg

Cerebrospinal fluid levels of pterin cofactor were measured in off-medication schizophrenic patients and normal control subjects as one aspect of monoamine physiology in schizophrenia. Pterin cofactor is essential for the hydroxylation of several substances including tyrosine, the rate-limiting step in the synthesis of dopamine and norepinephrine. No significant differences were found. Platelet monoamine oxidase activity correlated significantly with pterin levels in male schizophrenic and in female control subjects.


Archive | 1995

Effects of TA-0910, a Thyrotropin-Releasing Hormone Analog, on Alcohol Intake in Alcohol-Preferring Rats

George A. Mason; Amir H. Rezvani; James C. Garbutt

Alcoholism, perhaps the oldest addictive illness, remains a serious problem affecting nearly all ethnic and socioeconomic groups. Its genetic and neurobiologie origins are complex, and many different neuronal systems are likely to be involved in the processes leading to its development and maintenance.1,2 Various aspects of excessive drinking behavior have been studied in rodent models developed through selective breeding of animals that showed spontaneous preference for alcohol. Strains of rats bred in this manner voluntarily ingest alcohol in quantities sufficient to produce physical dependence and are considered to model some aspects of human alcoholism. One such model is the well-known strain of alcohol-preferring (P) rats developed by Li and colleagues.3,4Using this model, behavioral and pharmacological evidence has been derived linking excessive alcohol consumption to altered serotonergic, dopaminergic, and GABAergic systems.5


Alcoholism: Clinical and Experimental Research | 1998

Preference for higher sugar concentrations and Tridimensional Personality Questionnaire scores in alcoholic and nonalcoholic men

Alexey B. Kampov-Polevoy; James C. Garbutt; C. E. Davis; David S. Janowsky


American Journal of Psychiatry | 1986

Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.

James C. Garbutt; Mayo Jp; Gillette Gm; Karley Y. Little; George A. Mason


Journal of Studies on Alcohol and Drugs | 1991

Dose-response studies with thyrotropin-releasing hormone (TRH) in abstinent male alcoholics: evidence for selective thyrotroph dysfunction?

James C. Garbutt; Mayo Jp; Gillette Gm; K Y Little; R E Hicks; G A Mason; A J Prange


Alcoholism: Clinical and Experimental Research | 1992

Evidence for Normal Feedback Inhibition of Triiodothyronine on the Thyrotropin (TSH) Response to Thyrotropin‐Releasing Hormone (TRH) in Abstinent Male Alcoholics

James C. Garbutt; Joshua McDavid; George A. Mason; Dana Quade; Peter T. Loosen


Archive | 1992

Thyroid Hormones and Alcoholism

Peter T. Loosen; Samuel Sells; Thomas D. Geracioti; James C. Garbutt


Neuroendocrinology Letters | 1991

Failure of chlordiazepoxide to antagonize the thyrotropin of prolactin response to thyrotropin-releasing hormone in humans

J. A. Wainer; James C. Garbutt; Gillette Gm; G. A. Mason; Quade De

Collaboration


Dive into the James C. Garbutt's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

George A. Mason

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alexey B. Kampov-Polevoy

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mayo Jp

Dorothea Dix Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arthur J. Prange

University of North Carolina at Chapel Hill

View shared research outputs
Researchain Logo
Decentralizing Knowledge